Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive-care-unit-acquired infection related to multidrug-resistant bacteria: a prospective uncontrolled before–after study

Clinical Microbiology and Infection

Volumn 22, Issue 10, 2016, Pages 888.e11-888.e18

  Ledoux, G ^a   Six, S ^a   Lawson, R ^a   Labreuche, J ^a   Blazejewski, C ^b   Wallet, F ^a   Duhamel, A ^a,c   Nseir, S ^a,c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CH Dunkerque   (France)

^c UNIV LILLE   (France)

Author keywords

Colonization; Contact precautions; Critical illness; Infection control; Intensive care; Isolation; Multidrug resistant bacteria

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ATTRIBUTABLE RISK; CRITICALLY ILL PATIENT; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NEUROLOGIC DISEASE; NONHUMAN; PATIENT ISOLATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SHOCK; CROSS INFECTION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES;

ADULT; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PATIENT ISOLATION; PROSPECTIVE STUDIES;

EID: 84995598183     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.07.012     Document Type: Article

References (37)

1. [1] Vincent, J.-L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C.D., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302 (2009), 2323–2329.
2. [2] Bassetti, M., De Waele, J.J., Eggimann, P., Garnacho-Montero, J., Kahlmeter, G., Menichetti, F., et al. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41 (2015), 776–795.
3. [3] Tabah, A., Koulenti, D., Laupland, K., Misset, B., Valles, J., Bruzzi De Carvalho, F., et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 38 (2012), 1930–1945.
4. [4] Micek, S.T., Wunderink, R.G., Kollef, M.H., Chen, C., Rello, J., Chastre, J., et al. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance. Crit Care, 19, 2015, 219.
5. 2-agonists and ventilator-associated pneumonia: a cohort study. Crit Care Med 39 (2011), 725–730.
6. [6] Tacconelli, E., Cataldo, M.A., Dancer, S.J., De Angelis, G., Falcone, M., Frank, U., et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20 (2014), 1–55.
7. [7] Otter, J.A., Mutters, N.T., Tacconelli, E., Gikas, A., Holmes, A.H., Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries. Clin Microbiol Infect 21 (2015), 1057–1066.
8. [8] Blazejewski, C., Wallet, F., Rouzé, A., Le Guern, R., Ponthieux, S., Salleron, J., et al. Efficiency of hydrogen peroxide in improving disinfection of ICU rooms. Crit Care, 19, 2015, 30.
9. [9] Siegel JD, Rhinehart E, Jackson M CL. 2007 Guidelines for isolation precautions: preventin transmission of infectious agents in healthcare settings. http://www.cdc.gov/ncidod/pdf/isolation2007.pdf n.d.
10. [10] Robicsek, A., Beaumont, J.L., Paule, S.M., Hacek, D.M., Thomson, R.B., Kaul, K.L., et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148 (2008), 409–418.
11. [11] Jain, R., Kralovic, S.M., Evans, M.E., Ambrose, M., Simbartl, L a, Obrosky, D.S., et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med 364 (2011), 1419–1430.
12. [12] Gbaguidi-Haore, H., Legast, S., Thouverez, M., Bertrand, X., Talon, D., Ecological study of the effectiveness of isolation precautions in the management of hospitalized patients colonized or infected with Acinetobacter baumannii. Infect Control Hosp Epidemiol 29 (2008), 1118–1123.
13. [13] Cepeda, J.A., Whitehouse, T., Cooper, B., Hails, J., Jones, K., Kwaku, F., et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 365 (2005), 295–304.
14. [14] Derde, L.P.G., Cooper, B.S., Goossens, H., Malhotra-Kumar, S., Willems, R.J.L., Gniadkowski, M., et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 14 (2014), 31–39.
15. [15] Huang, S.S., Septimus, E., Kleinman, K., Moody, J., Hickok, J., Avery, T.R., et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368 (2013), 2255–2265.
16. [16] Huskins, W.C., Huckabee, C.M., O'Grady, N.P., Murray, P., Kopetskie, H., Zimmer, L., et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 364 (2011), 1407–1418.
17. [17] Zahar, J.R., Garrouste-Orgeas, M., Vesin, A., Schwebel, C., Bonadona, A., Philippart, F., et al. Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events. Intensive Care Med 39 (2013), 2153–2160.
18. [18] Abad, C., Fearday, A., Safdar, N., Adverse effects of isolation in hospitalised patients: a systematic review. J Hosp Infect 76 (2010), 97–102.
19. [19] Harbarth, S., Masuet-Aumatell, C., Schrenzel, J., Francois, P., Akakpo, C., Renzi, G., et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care, 10, 2006, R25.
20. [20] Martin-Loeches, I., Torres, A., Rinaudo, M., Terraneo, S., de Rosa, F., Ramirez, P., et al. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. J Infect 70 (2015), 213–222.
21. [21] Nseir, S., Grailles, G., Soury-Lavergne, A., Minacori, F., Alves, I., Durocher, A., Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission. Clin Microbiol Infect 16 (2010), 902–908.
22. [22] Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 (2005), 388–416.
23. [23] Nseir, S., Di Pompeo, C., Pronnier, P., Beague, S., Onimus, T., Saulnier, F., et al. Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J 20 (2002), 1483–1489.
24. [24] Rosenthal, V.D., Maki, D.G., Mehta, Y., Leblebicioglu, H., Memish, Z.A., Al-Mousa, H.H., et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007–2012. Device-associated module. Am J Infect Control 42 (2014), 942–956.
25. [25] Zou, G., A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 159 (2004), 702–706.
26. [26] Morgan, D.J., Diekema, D.J., Sepkowitz, K., Perencevich, E.N., Adverse outcomes associated with Contact Precautions: a review of the literature. Am J Infect Control 37 (2009), 85–93.
27. [27] Kirkland, K.B., Weinstein, J.M., Adverse effects of contact isolation. Lancet (London, England) 354 (1999), 1177–1178.
28. [28] Morgan, D.J., Pineles, L., Shardell, M., Graham, M.M., Mohammadi, S., Forrest, G.N., et al. The effect of contact precautions on healthcare worker activity in acute care hospitals. Infect Control Hosp Epidemiol 34 (2013), 69–73.
29. [29] Stelfox, H.T., Bates, D.W., Redelmeier, D.A., Safety of patients isolated for infection control. JAMA 290 (2003), 1899–1905.
30. [30] Wolkewitz, M., Cooper, B.S., Palomar-Martinez, M., Alvarez-Lerma, F., Olaechea-Astigarraga, P., Barnett, A.G., et al. Multilevel competing risk models to evaluate the risk of nosocomial infection. Crit Care, 18, 2014, R64.
31. [31] Martín-Loeches, I., Diaz, E., Vallés, J., Risks for multidrug-resistant pathogens in the ICU. Curr Opin Crit Care 20 (2014), 516–524.
32. [32] Saulnier, F.F., Hubert, H., Onimus, T.M., Beague, S., Nseir, S., Grandbastien, B., et al. Assessing excess nurse work load generated by multiresistant nosocomial bacteria in intensive care. Infect Control Hosp Epidemiol 22 (2001), 273–278.
33. [33] Hugonnet, S., Chevrolet, J.-C., Pittet, D., The effect of workload on infection risk in critically ill patients. Crit Care Med 35 (2007), 76–81.
34. [34] Surveillance des infections nosocomiales en réanimation adulte. Réseau REA-Raisin, France, résultats 2013. http://www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses/Maladies-infectieuses/2015/Surveillance-Des-Infections-Nosocomiales-En-Reanimation-Adulte n.d.
35. [35] Cohen, C.C., Cohen, B., Shang, J., Effectiveness of contact precautions against multidrug-resistant organism transmission in acute care: a systematic review of the literature. J Hosp Infect 90 (2015), 275–284.
36. [36] Kullar, R., Vassallo, A., Turkel, S., Chopra, T., Kaye, K.S., Dhar, S., Degowning the controversies of contact precautions for methicillin-resistant Staphylococcus aureus: a review. Am J Infect Control 44 (2016), 97–103.
37. [37] Sypsa, V., Psichogiou, M., Bouzala, G.-A., Hadjihannas, L., Hatzakis, A., Daikos, G.L., Transmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit. PLoS One, 7, 2012, e41068.